Provision of IgG/IgM ELISA Test Kits (Lyme C6)

Public Health England (PHE) is seeking to procure a Borrelia combined IgG/IgM ELISA suitable for screening Human Sera (and potentially CSF) from suspected Lyme disease patients. This contract is for a period of 1 year with the possibility of extension for a further 3 periods of 12 months (+3), reviewed annually.